BC
KZR

BIT Capital’s Kezar Life Sciences KZR Stock Holding History

BIT Capital’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,037
Closed -$786K – 164
2022
Q4 		$786K Buy
11,037
+4,211
+62% +$312K 0.16% 50
2022
Q3 		$588K Buy
6,826
+2,756
+68% +$268K 0.11% 59
2022
Q2 		$356K Sell
4,070
-3,205
-44% -$283K 0.05% 83
2022
Q1 		$1.2M Sell
7,275
-3,725
-34% -$535K 0.11% 63
2021
Q4 		$1.44M Buy
+11,000
New +$1.24M 0.11% 70

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

BIT Capital's KZR Position: Q1 2023 in Review

BIT Capital sold out of Kezar Life Sciences (KZR) in Q1 2023, closing a stake of 11,037 shares — an estimated $786K sold.

BIT Capital first reported a position in KZR in Q4 2021 and held it in 5 quarters. The position peaked at $1.44M in Q4 2021. 136 funds tracked by Wall St. Rank hold KZR as of Q1 2023.

  • BIT Capital reported no remaining Kezar Life Sciences position as of Q1 2023 after selling out during the quarter.
  • BIT Capital sold 11,037 Kezar Life Sciences shares in Q1 2023, an estimated $786K.
  • BIT Capital first reported a position in Kezar Life Sciences in Q4 2021 and held it in 5 quarters.
  • BIT Capital's Kezar Life Sciences position peaked at $1.44M in Q4 2021.
  • 136 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q1 2023.

Based on BIT Capital's 13F filing for Q1 2023, filed 12 Feb 2025.